Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1975 7
1976 2
1977 5
1978 7
1979 7
1980 6
1981 7
1982 5
1983 13
1984 14
1985 13
1986 11
1987 10
1988 18
1989 15
1990 15
1991 20
1992 21
1993 25
1994 28
1995 15
1996 15
1997 13
1998 10
1999 11
2000 7
2001 11
2002 13
2003 10
2004 14
2005 8
2006 20
2007 19
2008 11
2009 24
2010 30
2011 25
2012 19
2013 11
2014 19
2015 30
2016 28
2017 26
2018 39
2019 18
2020 26
2021 30
2022 37
2023 36
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

775 results

Results by year

Filters applied: . Clear all
Page 1
Long-term outcomes of R-CEOP show curative potential in patients with DLBCL and a contraindication to anthracyclines.
Moccia AA, Schaff K, Freeman C, Hoskins PJ, Klasa RJ, Savage KJ, Shenkier TN, Gascoyne RD, Connors JM, Sehn LH. Moccia AA, et al. Blood Adv. 2021 Mar 9;5(5):1483-1489. doi: 10.1182/bloodadvances.2020002982. Blood Adv. 2021. PMID: 33683338 Free PMC article.
The 10-year time to progression and disease-specific survival were not significantly different for patients treated with R-CEOP compared with patients in the R-CHOP control group (53% vs 62% [P = .089] and 58% vs 67% [P = .251], respectively). The 10-year overall su …
The 10-year time to progression and disease-specific survival were not significantly different for patients treated with R-CEOP compared wit …
Association of Social Determinants and Tumor Biology With Racial Disparity in Survival From Early-Stage, Hormone-Dependent Breast Cancer.
Hoskins KF, Calip GS, Huang HC, Ibraheem A, Danciu OC, Rauscher GH. Hoskins KF, et al. JAMA Oncol. 2023 Apr 1;9(4):536-545. doi: 10.1001/jamaoncol.2022.7705. JAMA Oncol. 2023. PMID: 36795405 Free PMC article.

Neighborhood disadvantage and insurance status together mediated 19% of the disparity (mediated HR, 1.62; 95% CI, 1.31-2.00; P < .001) and tumor biological characteristics mediated 20% (mediated HR, 1.56; 95% CI, 1.28-1.90; P < .001). A fully adjusted model th

…

Neighborhood disadvantage and insurance status together mediated 19% of the disparity (mediated HR, 1.62; 95% CI, 1.31-2.00; P < .

…
Pharmacogenetics of breast cancer therapies.
Hertz DL, McLeod HL, Hoskins JM. Hertz DL, et al. Breast. 2009 Oct;18 Suppl 3:S59-63. doi: 10.1016/S0960-9776(09)70275-9. Breast. 2009. PMID: 19914545 Free article. Review.
Bacterial Hsp90 ATPase Assays.
Hoskins JR, Wickner S, Doyle SM. Hoskins JR, et al. Methods Mol Biol. 2018;1709:199-207. doi: 10.1007/978-1-4939-7477-1_15. Methods Mol Biol. 2018. PMID: 29177661 Free PMC article.
The second assay is a more sensitive method that directly quantifies the radioactive inorganic phosphate released following the hydrolysis of [gamma-(33)P] ATP or [gamma-(32)P] ATP....
The second assay is a more sensitive method that directly quantifies the radioactive inorganic phosphate released following the hydrolysis o …
Engaging Historically Black Undergraduate Students in Geriatric Mental Health.
Hoskins TF, Smith AT, McWilliams XA, Cox KL, Morgan R, Joshi P, Dix E, Kapoor A, Hendrie K, Perez-Palmer N, Kozar V, Black C. Hoskins TF, et al. Am J Geriatr Psychiatry. 2024 Mar;32(3):263-266. doi: 10.1016/j.jagp.2023.12.013. Epub 2023 Dec 21. Am J Geriatr Psychiatry. 2024. PMID: 38143190 No abstract available.
Topotecan for ovarian cancer.
Lihua P, Chen XY, Wu TX. Lihua P, et al. Cochrane Database Syst Rev. 2008 Apr 16;2008(2):CD005589. doi: 10.1002/14651858.CD005589.pub2. Cochrane Database Syst Rev. 2008. PMID: 18425923 Free PMC article. Review.
MAIN RESULTS: Six studies including 1323 participants were eligible for this review (Gordon 2004a; Gore 2001a; Gore 2002; Hoskins 1998; Huinink 2004; Placido 2004) All studies, as reported, were identified as being of poor methodological quality. Topotecan had comparable e …
MAIN RESULTS: Six studies including 1323 participants were eligible for this review (Gordon 2004a; Gore 2001a; Gore 2002; Hoskins 199 …
Neurotoxicants and gamma-aminobutyric acid receptors.
Ho IK, Hoskins B. Ho IK, et al. J Toxicol Sci. 1990 Dec;15 Suppl 4:3-13. doi: 10.2131/jts.15.supplementiv_3. J Toxicol Sci. 1990. PMID: 1966056 Free article. Review. No abstract available.
775 results